Schizophrenia | Progress In Mind

Home

Congress highlights

Can blue-depleted light decrease duration of psychiatric hospitalization?

Novel light and sensor technologies have been installed in a new acute psychiatric unit in Norway...

Congress highlights

Core components of the Coordinated Specialty Care model for first-episode psychosis

The Coordinated Specialty Care (CSC) model for first-episode psychosis (FEP) is an evidence-based...

Congress highlights

Early dialogues with patients are informing medicines development

A 200-strong audience of health economics and outcomes research professionals at ISPOR 2018...

Congress highlights

Neuroimaging, antipsychotics and registries – functional capacity

Neuroimaging studies of response to antipsychotic therapies and glutamate levels in first-episode...

Video #8: Initiation of long-acting injectable antipsychotic treatment in patients with schizophrenia

Video #7: Long-acting injectable antipsychotics in the treatment plan of patients with schizophrenia

Video #6: Which patients are best suited for long-acting injectable antipsychotics?

Video #5: Early intervention in schizophrenia is key for the long-term prognosis of the disease

Congress highlights

The new technologies transforming psychiatric practice and patient outcomes

Data-driven approaches to psychiatric diagnosis and practice fueled by the abundance of information...

Video #4: Discussing the benefit of long-acting injectable antipsychotics with patients and carers

Video #2: Patients at the center

Congress highlights

Better safe than sorry? Knowns and unknowns in the maintenance treatment of remitted first-episode psychotic disorders

Psychotic disorders, including schizophrenia and related disorders, which affect up to 3% of the...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind South Africa

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind South East Asia
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in South East Asia click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline